CD20/MS4A1 Human Monoclonal Antibody
Anti-Human CD20/MS4A1 (BPCX228) is a research-grade recombinant antibody targeting CD20. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
UniProt
P11836
Reactivity
Human
Clonality
Monoclonal
Clone
BPCX228
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Tert-Butyl N-{[3- (piperidin-4-yl) -1H-1,2,4-triazol-5-yl]methyl}carbamate](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
XLD55983-01 50 mg
Tert-Butyl N-{[3- (piperidin-4-yl) -1H-1,2,4-triazol-5-yl]methyl}carbamate
Sign In for Pricing
View Details XLD55983-02 0.5 g
Tert-Butyl N-{[3- (piperidin-4-yl) -1H-1,2,4-triazol-5-yl]methyl}carbamate
Sign In for Pricing
View Details